Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study-Reference-Cited by-同舟云学术

Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study

Published:2017-02 Issue:2 Volume:4 Page:e75-e82
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Fischer Kathelijn,Kulkarni Roshni,Nolan Beatrice,Mahlangu Johnny,Rangarajan Savita,Gambino Giulia,Diao Lei,Ramirez-Santiago Alejandra,Pierce Glenn F,Allen Geoffrey

Publisher

Elsevier BV

Subject

Hematology

Reference28 articles.

1. Haemophilia and joint disease: pathophysiology, evaluation, and management;Knobe;JOC,2011

2. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia;Fischer;Blood,2002

3. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized;Astermark;Br J Haematol,1999

4. Barriers to compliance with prophylaxis therapy in haemophilia;Hacker;Haemophilia,2001

5. Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey;Zappa;Haemophilia,2012

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B;Blood Advances;2024-09-24

2. Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment;Expert Opinion on Investigational Drugs;2024-08-11

3. Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany;Research and Practice in Thrombosis and Haemostasis;2024-07

4. Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B‐LONG study;European Journal of Haematology;2024-06-25

5. Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors;Advances in Therapy;2024-04-23